Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Liver cancer
We need you in the fight against liver cancer, join # OctoberIs4Livers 2021
We are pleased to announce that this year's # OctoberIs4Livers, GLI's liver cancer education and awareness campaign kicks off with a special edition of GLI LIVE featuring Dr. Ned Sharpless, Director of the National Cancer Institute ( NCI).…
Liver Cancer Therapy Market Report Covers Future Trends With Research 2021-2028 – ArQule,…
Liver cancer is cancer that begins in the cells of the liver. It is a chronic, life-threatening and progressive disorder that begins in the cells of the liver. Liver cancer can be of different types, such as cancer that starts in…
Assessment of miRNA expression in cirrhosis and liver cancer
Oncotarget published "Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer," which reported that patients with HCV-related cirrhosis are at risk for developing cancer of the liver.…
Hope on the horizon for liver cancer patients as company drug Namodenoson enters pivotal Phase III…
photo by National Cancer Institute to UnsplashLiver cancer is a growing global health problem. In addition to the financial burden it places on patients and economies, the American Cancer Society has revealed that by the end of 2021,…
Liver cancer researcher Dr Abir Arfaoui named latest Brave Fellow
Tell us about your research project.
Fibrolamellar carcinoma is characterized by a chimeric protein called DNAJ-PKA which exists on all cancer cells. A chimeric protein is a fusion between two proteins on chromosome 19. This chimeric…
Rural areas see rising incidence of liver cancer
Although they represent only 15% of new cases of hepatocellular carcinoma (HCC), the most common type of liver cancer, HCC levels are rising faster among rural populations than in urban areas. Indeed, the rate of new…
Cytochrome P450-2D6: a new biomarker in the health disparity of liver cancer
This article was originally published here
PLoS One. Oct 1, 2021; 16 (10): e0257072. doi: 10.1371 / journal.pone.0257072. Electronic collection 2021.
ABSTRACT
Morbidity and mortality rates from liver cancer differ among ethnic…
Cytochrome P450-2D6: a new biomarker in the health disparity of liver cancer
This article was originally published here
PLoS One. Oct 1, 2021; 16 (10): e0257072. doi: 10.1371 / journal.pone.0257072. Electronic collection 2021.
ABSTRACT
Morbidity and mortality rates from liver cancer differ among ethnic…
$ 17 million liver cancer research grant goes to NCSU researchers
RALEIGH - NC State researchers have received a $ 17 million grant from the National Institutes of Health (NIH) to explore a potential link between environmental contaminants and liver cancer.
Led by Cathrine Hoyo, Professor…
Chemotherapy / immunotherapy approach shows promise in intermediate stage liver cancer
A new treatment option for transarterial chemoembolization (TACE) plus Opdivo (nivolumab) may hold promise for patients with intermediate-stage liver cancer, according to the results of a clinical trial.TACE is a method that delivers…